Arrowhead Pharma (ARWR) PT Raised at RBC Capital Following Redemplo Approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 59.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.90 | 52 Week High | $8.22 | |||
| Open | $59.90 | 52 Week Low | $3.07 | |||
| Day High | $59.90 | P/E | N/A | |||
| Day Low | $59.90 | EPS | $-1.30 | |||
| Volume | 28 | |||||
